Principle Diagnostics

Laboratory Service

We track the truth. 

Principle Diagnostics Laboratory (PDL) is a state of the art laboratory, specializing in the testing of toxicology and wellness for all clientele. Licensed in over 40 states, PDL tracks the truth in every sample to make sure all health care organizations are able to properly diagnose their patients.

 

Toxicology

•    Analyzed thru either Urine or Oral fluids

•    Principle Diagnostics offers Specimen Validity, Presumptive

Qualitative Drug Screening and Quantitative Drug Confirmation

•    Turn around time of 24-48 hours
•    Results thru fax, portal or delivery of hard copy reports
•    A vast list of over 100 analytes and adaptive to newly introduced

      substances including these Key Analyst:​

​

Kratom

Fentanyl Analogs

Opiates

Opioids and opiate analogs

Synthetic cannabinoid (K2 spice)

 

Clinical Blood

​

With our immunoassay technology we offer a wide range of clinical blood-testing that covers a broad spectrum of specialties:


Chemistry

Hematology 
Urinalysis
Endocrinology
Immunology
Virology
Oncology

 

Genetics

Principle offers Genetic Testing for many disciplines:

​

Cancer Genetics

Genetic Testing for Cancer accurately assesses your risk of developing certain forms of cancer in your lifetime. A person with a strong family or personal history of certain types of cancer to see if they carry a gene mutation that increased their risk.

Cardiac Genetics

Genetic Testing for a hereditary assessment of Cardiac Conditions

Metabolic Genetics

Genetic testing for Diabetes/Obesity accurately assesses the risk level of developing this disease. 

      Neuro Genetics

Genetic Testing for Parkinson’s, Alzheimer’s, and Dementia accurately assess the risk level of developing any of these neurological diseases.

 

Molecular Testing: UTI

Comprehensive panel detecting, by Molecular Technique, urinary pathogens. 

Testing with high sensitivity and specificity compared to the traditional urine culture technique. We identify pathogens difficult to grow in culture and use the largest pathogen menu available. 

 

Fiscally Responsible Urinary Infection Testing Option. 

  • This panel will reflex from Urinalysis to UTI ID 

  • Panel-based on the same criteria as the traditional UA, culture if indicated 

  • Patients avoid the higher cost of UTI ID Panel if unnecessary 

  • Ensures only medically necessary testing is conducted 

  • E. Coli 

  • Staphylococcus aureus 

  • Staphylococcus saprophyticus 

  • Enterococcus faecalis 

  • Ureaplasma urealyticum 

  • Mycoplasma hominis 

  • Candida species 

  • Proteus mirabilis 

  • Klebsiella pneumoniae 

  • Morganella moranii 

  • Serratia marescens 

  • Klebsiella oxytoca 

  • Enterobacter cloacae 

  • Providence suartii 

  • Psuedomonas aeruginosa 

  • Streptococcus agalactiae 

  • “Resistance Markers”(via PCR) 

  • Antibiotic Sensitivity (Via culture

Molecular Testing: RPP

Respiratory Pathogen Panel (RPP) via PCR Technology

 

Developed to broaden and streamline testing for multiple viral and bacterial agents of the upper respiratory tract.

​

Now practitioners and patients can benefit from the quickest and most accurate diagnosis possible.

​

PCR swiftly pinpoints the influenza virus, along with a number of other respiratory viruses and pneumonia

causing bacteria.

​

• One comprehensive panel provides rapid,

accurate, and simultaneous detection of

multiple Bacterial, Viral, and Fungal targets.

 

• “72 hour” turn-around time on test results

 

• Identifies Antibiotic Resistance Markers

  • Contributes to improved Antibiotic Stewardship

​

​

• Includes Enhanced Treatment Guidance

  • Reduces treatment failures

​

• Unmatched accuracy of PCR

​

• Use for Rapid Flu Test validation

​

• Simple nasal swab collection

Pathogens Detected 

Viral Targets

• Influenza Panel

• Influenza A

• Influenza A/H1-2009

• Influenza A/H3

• Influenza B

• Influenza C

• Common Cold Panel

• Adenovirus

• Coronavirus (HKU1/NL63/229E OC43)

• Human Rhinovirus

• Human Enterovirus

• Bocavirus

• Parechovirus

• Respiratory Syncytial Virus A/B

• Human Metapneumovirus A/B

Bacterial Targets

• Pneumonia Panel

• Mycoplasma pneumoniae

• Chlamydia pneumoniae

• Streptococcus pneumoniae

• Klebsiella pneumoniae

• Haemophilus influenzae

• Haemophilus influenzae (Type B)

• Legionella pheumophila

• Legionella longbeachae

• Moraxella catarrhalis

• Whooping Cough (Pertussis)

• Staphylococcus aureus w/reflex

to MRSA

Fungal Targets

• Pneumocystis jirovecii

• “Resistance Markers”

• “Enhanced Treatment Guidance”